Summary of Key Points Core Viewpoint - The report highlights a total of 192 financing events disclosed in the week from June 16 to June 22, 2025, involving 143 domestic companies and 49 foreign companies, with a total financing amount of approximately 2327.76 billion RMB. The medical health sector leads in the number of events, while the low-carbon sector leads in financing amount [2]. Domestic Financing Events - The medical health sector disclosed 42 financing events, involving 25 domestic companies and 17 foreign companies, with a total financing amount of approximately 162.68 billion RMB [2]. - Notable domestic events include: - Jian Yong Sheng Ji went public, focusing on plant-based innovative drug development [2]. - Hongze Lake Dashi was acquired by Hongze Lake Construction, providing integrated health services [2]. - Jianfu Tang Chinese Medicine Group was acquired by Jianbei Miao Miao, specializing in traditional Chinese medicine services [2]. - Huashitong Bio was acquired by Kelun Pharmaceutical, focusing on drug development [2]. - Zhejiang Taide Pharmaceutical completed a $10 million Pre-IPO financing round [2]. - Shengda Pharmaceutical received a strategic investment of 260 million RMB, ranking in the top 50 for strategic investments this year [2]. - Other companies like Shuyaqi, Jingzhi Future, and Suzhou Guoke Xin Gan Medical Technology also received strategic investments [2][3]. Foreign Financing Events - The foreign medical health sector saw 1 company go public, 1 company acquired, and 15 companies receiving investments, totaling approximately 137.86 billion RMB [4]. - Key foreign events include: - Caris Life Sciences went public, focusing on biopharmaceutical services [5]. - Verve Therapeutics was acquired, specializing in gene editing technology [6]. - InSilico Medicine raised $123 million in strategic investment, ranking in the top 20 for this year's strategic investments [6]. - Corvia Medical and Sword Health also received significant strategic investments, ranking in the top 50 for their respective rounds [6]. Investment Trends - The report indicates a strong trend in the medical health sector, with numerous companies receiving substantial investments across various stages of financing, reflecting a robust interest in healthcare innovation and technology [2][4][6].

Group 1 - Jyong Biotech Ltd. (MENS) has filed proposed terms to raise $18.8 million from the sale of its common stock in an IPO [1] - The filing is part of an amended F-1/A SEC registration statement [1] Group 2 - IPO Edge, led by an investing group, provides actionable information on growth stocks, including first-look IPO filings and an IPO calendar [2] - The platform also offers a database of U.S. IPOs and a guide to IPO investing, covering the entire IPO lifecycle [2]